Table 4.
Lignans as inhibitors of TNF-α and neuroinflammatory responses in neurodegenerative diseases
Lignans | Source | Disease | Mechanism | IC50/dose | Model | Reference |
---|---|---|---|---|---|---|
Schisandrin A | Schisandra chinesnesis | PD | Inhibits the production of NO, TNF-α and IL-6 | 10, 20 and 50 μM | Rat cortical cells | Song et al., 2016 |
Schisandrin B (Gomisin N) | Schisandra chinesnesis | PD | Suppresses the expression of NO, TNF-α, PGE-2, IL-1β and IL-6 | 5, 10 or 20 mM | Rat primary neuron–microglia | Zeng et al., 2012 |
Schisandrin B (Gomisin N) | Schisandra chinensis | PD | Decreases indoleamine 2,3 dioxygenase expression, and TNF-α, IL-1β and IL-6 | 10 mg/kg/d | Mice | Sun et al., 2014 |
Honokiol, magnolol | Magnolia officinalis | AD | Induces NGF and BDNF secretion, inhibits TNF-α, NF-κB, IL-1β, IL-6, and ROS levels, and increases Akt activity | 100, 50, 10, and 1 μM | PC12 cells | Hoi et al., 2010 |
AD: Alzheimer’s disease; ERK: extracellular signal-regulated kinase; iNOS: inducible nitric oxide synthase; NGF: nerve growth factor; PD: Parkinson’s disease; ROS: reactive oxygen species; TNFα: tumor necrosis factor alpha; TNFR: tumor necrosis factor alpha receptor.